About Lymphoma | Advocacy | Art | CAM | Clinical trials | Doctors - Experts - Centers | Guidelines at Diagnosis | News
Risk Factors | Side Effects | Statistics | Support | Symptoms | Tests | Treatments | Types of Lymphoma

Search Site         Guidelines at Diagnosis | About Clinical Trials            How to Help!

Patients Against Lymphoma

 

Treatment Overview > Refractory > Phase III

Last update: 02/21/2003

Phase III Randomized Study of Interleukin-2 Versus Observation Only After Total Body Irradiation, High-Dose Etoposide, Cyclophosphamide, and Autologous Peripheral Blood Stem Cell Transplantation in Patients With Adult Non-Hodgkin's Lymphoma

Phase III Randomized Study of Two Different Sustained Release Formulations of Morphine Followed By Dextromethorphan or Placebo Plus Morphine for Patients with Chronic Cancer Pain

Phase III Study of Epratuzumab in Patients With Rituximab-Refractory Low-Grade Follicular B-Cell Non-Hodgkin's Lymphoma

 
Disclaimer:  The information on Lymphomation.org is not intended to be a substitute for 
professional medical advice or to replace your relationship with a physician.
For all medical concerns,  you should always consult your doctor. 
Patients Against Lymphoma, Copyright 2004,  All Rights Reserved.